Pharmacokinetics of a polyene antifungal agent, liposomal amphotericin B (L-AMB), in a severely burned patient

被引：3
|
作者：
Sasaki, Junichi [1 ]
Matsumoto, Kana [2 ]
Fujishima, Seitaro [1 ]
Morita, Kunihiko [2 ]
Hori, Shingo [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Emergency & Crit Care Med, Tokyo 1608582, Japan
[2] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Kyoto, Japan
来源：
JOURNAL OF CHEMOTHERAPY | 2014年 / 26卷 / 05期
关键词：
MICAFUNGIN; AMBISOME; CANDIDA; ESCHAR; PLASMA;
D O I：
10.1179/1973947813Y.0000000141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：312 / 314
页数：3
相关论文
共 37 条
  • [1] An Evaluation of Hepatotoxicity and Nephrotoxicity of Liposomal Amphotericin B (L-AMB)
    Patel G.P.
    Crank C.W.
    Leikin J.B.
    Journal of Medical Toxicology, 2011, 7 (1) : 12 - 15
  • [2] LIPOSOMAL AMPHOTERICIN B (L-AMB) TWICE WEEKLY AS ANTIFUNGAL PROPHYLAXIS IN PEDIACTRIC CANCER PATIENTS
    Lehrnbecher, Thomas
    Schedler, Nadine
    Tramsen, Lars
    Becker, Martina
    Klingebiel, Thomas
    Bochennek, Konrad
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 948 - 949
  • [3] Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children
    Sunakawa, Keisuke
    Tsukimoto, Ichiro
    Tsunematsu, Yukiko
    Honda, Masatada
    Iwai, Naoichi
    Maniwa, Takashi
    Haigo, Hisamatsu
    Suzuki, Kota
    Mori, Takeshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (04) : 456 - 465
  • [4] Comparison of the nephrotoxic and antigungal effects of amphotericin B-deoxycholate (D-AmB) and liposomal amphotericin B (L-AmB).
    Sabra, R
    Zeinoun, N
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R524 - R524
  • [5] Retrospective comparison or lipid amphotericin B complex (ABLC) and liposomal amphotericin B (L-AMB) in the pediatric population.
    Sykes, RB
    Sahni, J
    Ellis, JM
    Kuti, JL
    PHARMACOTHERAPY, 2005, 25 (03): : 469 - 469
  • [6] COMPARATIVE NEPHROTOXICITY OF FREE AND LIPOSOMAL AMPHOTERICIN-B (AMB AND L-AMB) DURING CHRONIC ADMINISTRATION IN RATS
    LONQUET, P
    JOLY, V
    SETA, N
    FRIEDLANDER, G
    CARBON, C
    YENI, P
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 412 - 412
  • [7] Cost-Efficacy analysis of Liposomal Amphotericin B (L-AmB) versus Amphotericin B Lipid Complex (ABLC) in the empirical treatment of febrile neutropenia
    Eandi, Mario
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2005, 6 (04) : 333 - 347
  • [8] CANDIDA SEPSIS IN THE SEVERELY BURNED PATIENT - A SUCCESSFUL METHOD OF TREATMENT WITH LIPOSOMAL AMPHOTERICIN-B
    PALLUA, N
    SCHNEIDER, W
    UNFALLCHIRURG, 1992, 95 (12): : 641 - 643
  • [9] Pharmacokinetic evaluation of liposomal amphotericin B (L-AMB) in patients with invasive fungal infection: Population approach in Japanese pediatrics
    Ohata, Yuka
    Tomita, Yoshiko
    Suzuki, Kota
    Maniwa, Takashi
    Yano, Yoshitaka
    Sunakawa, Keisuke
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (06) : 400 - 409
  • [10] Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?
    Toulet, Delphine
    Debarre, Cecile
    Imbert, Christine
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (02) : 430 - 432
1234